Table 4.

Characterization of carcinogenic and noncarcinogenic health impacts of HCHs and DDTs for adults and children.

Adults
OCPs	Ingestion	Dermal Contact	Inhalation	∑ILCR	LADD	HQ
α-HCH	1.3542 × 10−7	8.9266 × 10−8	3.1386 × 10−10	2.2501 × 10−7	6.7708 × 10−8	3.3854 × 10−8
γ-HCH	1.2227 × 10−6	8.0447 × 10−7	2.8340 × 10−9	2.0320 × 10−6	6.1137 × 10−7	3.0568 × 10−7
β-HCH	1.4162 × 10−5	9.3052 × 10−6	3.2824 × 10−8	2.3502 × 10−5	7.0811 × 10−6	3.5405 × 10−6
δ-HCH	3.7582 × 10−7	2.4831 × 10−7	8.7105 × 10−10	6.2504 × 10−7	1.8791 × 10−7	9.3956 × 10−8
Ave HCHs	3.9740 × 10−6	2.6118 × 10−6	9.2107 × 10−9	6.5960 × 10−6	1.9870 × 10−6	9.9350 × 10−7
∑HCHs	1.5896 × 10−5	1.0447 × 10−5	3.6843 × 10−8	2.6384 × 10−5	7.9481 × 10−6	3.9740 × 10−6
p,p’-DDE	7.6892 × 10−7	1.0150 × 10−6	1.7821 × 10−9	1.7857 × 10−6	3.8402 × 10−7	5.4907 × 10−6
o,p’-DDT	6.1674 × 10−7	8.1409 × 10−7	1.4294 × 10−9	1.4323 × 10−6	3.0800 × 10−7	4.4120 × 10−6
p,p’-DDD	3.3432 × 10−7	4.4130 × 10−7	7.7486 × 10−10	7.7639 × 10−7	1.6701 × 10−7	2.3909 × 10−6
p,p’-DDT	2.6700 × 10−6	3.5245 × 10−6	6.1884 × 10−9	6.2007 × 10−6	1.3400 × 10−6	1.9130 × 10−5
Ave DDTs	1.0975 × 10−6	1.4487 × 10−6	2.5437 × 10−9	2.5488 × 10−6	5.4975 × 10−7	7.8559 × 10−6
∑DDTs	4.3900 × 10−6	5.7949 × 10−6	1.0175 × 10−8	1.0195 × 10−5	2.1990 × 10−6	3.1424 × 10−5
Ave OCPs	2.5357 × 10−6	2.0303 × 10−6	5.8772 × 10−9	4.5724 × 10−6	1.2684 × 10−6	4.4247 × 10−6
Children
α-HCH	3.5108 × 10−7	2.3161 × 10−7	3.1386 × 10−10	5.8340 × 10−7	1.7554 × 10−7	8.7769 × 10−8
γ-HCH	3.1701 × 10−6	2.0971 × 10−6	2.8340 × 10−9	5.2703 × 10−6	1.5850 × 10−6	7.9251 × 10−7
β-HCH	3.6717 × 10−5	2.4250 × 10−5	3.2824 × 10−8	6.1050 × 10−5	1.8358 × 10−5	9.1791 × 10−6
δ-HCH	9.7436 × 10−7	6.4477 × 10−7	8.7105 × 10−10	1.6201 × 10−6	4.8718 × 10−7	2.4359 × 10−7
Ave HCHs	1.0303 × 10−5	6.8059 × 10−6	9.2107 × 10−9	1.7131 × 10−5	5.1514 × 10−6	2.5757 × 10−6
∑HCHs	4.1213 × 10−5	2.7223 × 10−5	3.6843 × 10−8	6.8524 × 10−5	2.0606 × 10−5	1.0303 × 10−5
p,p’-DDE	1.9935 × 10−6	2.6314 × 10−6	1.7821 × 10−9	4.6249 × 10−6	9.9675 × 10−7	4.9837 × 10−7
o,p’-DDT	1.5989 × 10−6	2.1106 × 10−6	1.4294 × 10−9	3.7096 × 10−6	7.9947 × 10−7	3.9974 × 10−7
p,p’-DDD	8.6675 × 10−7	1.1441 × 10−6	7.7486 × 10−9	2.0109 × 10−6	4.3338 × 10−7	2.1669 × 10−7
p,p’-DDT	6.9223 × 10−6	9.1375 × 10−6	6.1884 × 10−9	1.6060 × 10−5	3.4612 × 10−6	1.7306 × 10−6
Ave DDTs	2.8454 × 10−6	3.7559 × 10−6	2.5437 × 10−9	6.6013 × 10−6	1.4227 × 10−6	7.1135 × 10−7
∑DDTs	1.1381 × 10−5	1.5024 × 10−5	1.0175 × 10−8	2.6405 × 10−5	5.6908 × 10−6	2.8454 × 10−6
Ave OCPs	6.5742 × 10−6	5.2809 × 10−6	5.8772 × 10−9	1.1866 × 10−5	3.2871 × 10−6	1.6435 × 10−6

ILCR is incremental lifetime cancer risks, LADD is lifetime average daily dose and HQ is hazard quotient.